« Back to Record
Citation APA

Von Minckwitz, G., Procter, M., de Azambuja, E., Zardavas, D., Benyunes, M., Viale, G., Suter, T., Arahmani, A., Rouchet, N., Clark, E., Knott, A., Lang, I., Levy, C., Yardley, D., Bines, J., Gelber, R., Piccart-Gebhart, M., & Baselga, J. (2017). [RETRACTED] Adjuvant pertuzumab and trastuzumab in early her2-positive breast cancer. The New England journal of medicine, 377(7), 702. doi:10.1056/NEJMoa1703643


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/259674

Von Minckwitz, G., Procter, M., de Azambuja, E., Zardavas, D., Benyunes, M., Viale, G., Suter, T., Arahmani, A., Rouchet, N., Clark, E., Knott, A., Lang, I., Levy, C., Yardley, D., Bines, J., Gelber, R., Piccart-Gebhart, M., & Baselga, J. (2017). [RETRACTED] Adjuvant pertuzumab and trastuzumab in early her2-positive breast cancer. The New England journal of medicine, 377(7), 702. doi:10.1056/NEJMoa1703643